Twelve new large-TAM startups: traction clusters below the top score, and the top score carries the most risk

Asked:

“find the best startups that just came out these last 12 months that have large TAMs.”

A screen of startups publicly launched or emerged from stealth between 2025-11-16 and 2026-11-16, distilled to a 12-company diligence watchlist backed by eleven independent source hosts (no startup URL backs more than one row). Funding ranges from $70M to $1.75B; comparable-market forecasts are third-party 2035 projections, directional only — not bottom-up TAMs. This is a curated shortlist, not full coverage of every launch in the window.

Screening score vs funding, sized by comparable-market forecast

Announced customers or production traction Pre-revenue / unproven — high execution risk Bubble area ∝ comparable 2035 market forecast ($B) · x-axis is log-scaled
Eridu tops the score (73.9) on a $274B AI-inference comparison and $230M raised — but has no announced customers and an unfinished product: high-upside, high-execution-risk. eridu.ai
Walden's robots have done production work at a Toyota plant since February — pilot to real work in under two months — the strongest industrial deployment signal on the list. waldenrobotics.com
XDOF reportedly approaches $50M annualized revenue with about 20 customers on just $70M raised — the best revenue-per-dollar-raised signal here. nuvastra.com
Joulent's $1.75B and a Microsoft-linked 2.67 GW project dwarf every other raise, but its automated market match (data-center switches) is weak — treat its bubble as indicative only. latitudemedia.com

Best by category

Strongest production traction
Walden Robotics — general-purpose robots doing production work at Toyota; strategic partners across six industries. waldenrobotics.com
Strongest revenue & customer traction
XDOF Robotics (~$50M annualized revenue, ~20 customers) and Artemis Security (several seven-figure deals; Mercury, Wix, Lemonade, Abnormal AI as clients). nuvastra.com · fortune.com
Biggest technical upside
Eridu Corporation — veteran networking team, $230M, $274B 2035 AI-inference comparison market; product unfinished and no announced customers. eridu.ai
Biotech moonshot
Syremis Therapeutics — Phase 1 dual M1/M4 agonist for schizophrenia, $165M, Karuna/Lilly pedigree, against a $150B mental-disorders drug market. syremis.com
Highest-risk capital-intensive bet
Joulent, LLC — $1.75B toward a 2.67 GW gas-powered facility under a 20-year Microsoft PPA; EPC supply chain, permits and project financing still ahead. latitudemedia.com

The ranked watchlist

#StartupLaunchScoreFundingComparable market (2035 forecast, CAGR)Traction & foundersStated riskLinks

Method: screening of startups publicly launched or emerged from stealth 2025-11-16 to 2026-11-16. Discovery merged 2,253 unique web results (semantic extraction on the first 2,000; 1,010 candidate mentions); targeted validation merged 2,370 results (1,119 rows); market research merged 2,324 results (1,227 rows). Final set: 12 rows, one per finalist, backed by 11 independent startup source hosts. The screening score blends semantic quality/traction, funding and market fit — a screening aid, not an investment recommendation. Comparable markets are automatically matched third-party forecasts in USD with differing definitions and years, not startup-specific TAMs. Traction and risk text shortened for space; full statements at the linked sources.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.

Keenable SELECTAsk your own question
Made with Keenable SELECT